Načítá se...
Ranolazine stabilizes cardiac Ryanodine receptors: a novel mechanism for the suppression of Early afterdepolarization and Torsade de Pointes in Long QT type 2
BACKGROUND: Ranolazine (Ran) is known to inhibit multiple targets, including: the late Na(+) current, I(Na), the rapid delayed rectifying K(+) current I(Kr), L-type Ca(2+) current I(Ca,L), and fatty-acid metabolism. Functionally, Ran suppresses early afterdepolarization (EADs) and Torsade de Pointes...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3335957/ https://ncbi.nlm.nih.gov/pubmed/22245792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hrthm.2012.01.010 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|